Women's Health News RSS Feed - Women's Health News

BUSM researchers find new way to detect and treat basal-like breast cancer

BUSM researchers find new way to detect and treat basal-like breast cancer

A new way to detect - and perhaps treat - one of the deadliest types of breast cancer has been found. Led by researchers at Boston University School of Medicine (BUSM), the study appears online in Breast Cancer Research. [More]
Researchers quantify growth and composition of breast tumours in living animal

Researchers quantify growth and composition of breast tumours in living animal

The ability to visualize and characterize the composition of a tumour in detail during its development can provide valuable insights in order to target appropriate therapeutics. [More]
WABA calls for global action to support women to combine breastfeeding and work

WABA calls for global action to support women to combine breastfeeding and work

This World Breastfeeding Week, WABA calls for concerted global action to support women to combine breastfeeding and work. [More]
2015 Lansinoh Breastfeeding Survey shows many women still struggle to breastfeed their babies

2015 Lansinoh Breastfeeding Survey shows many women still struggle to breastfeed their babies

The 2015 Lansinoh Breastfeeding Survey finds nearly all women (96%) agree that breastfeeding is the best way to feed their children, but many still struggle to breastfeed for what they believe to be the ideal amount of time. [More]
BRCA gene mutations and ovarian cancer: an interview with Dr Matulonis, Harvard Medical School

BRCA gene mutations and ovarian cancer: an interview with Dr Matulonis, Harvard Medical School

The BRCA gene encodes for the BRCA proteins, BRCA1 and BRCA2. These proteins are very important in repairing DNA, which they do by correcting double-stranded breaks. [More]
Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Eisai Inc. announced today that its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Halozyme Therapeutics, Inc. (Headquarters: San Diego, California, President and CEO: Dr. Helen Torley) have signed a clinical collaboration agreement to evaluate Eisai's agent eribulin mesylate (brand name: Halaven, "eribulin") in combination with Halozyme's investigational drug PEGPH20 (PEGylated recombinant human hyaluronidase) in first line HER2-negative metastatic breast cancer. [More]
Researchers gain new insight into the stages of breast cancer growth

Researchers gain new insight into the stages of breast cancer growth

The ability to visualize and characterize the composition of a tumour in detail during its development can provide valuable insights in order to target appropriate therapeutics. The polymer chemist Prof. Dr. Prasad Shastri and the pharmacist Jon Christensen, in collaboration with the biomedical researcher Dr. Daniel Vonwil, from the University of Freiburg have visualized and quantified the growth and composition of breast tumours over time in a living animal. [More]
Some breast cancer women can now undergo single-stage implant breast reconstruction

Some breast cancer women can now undergo single-stage implant breast reconstruction

Some women with breast cancer can now undergo a "one and done" approach combining nipple-sparing mastectomy with immediate single-stage implant (SSI) breast reconstruction in a single procedure, according to a report in the July issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons. [More]
Simple lifestyle intervention can help prevent gestational diabetes in high-risk women

Simple lifestyle intervention can help prevent gestational diabetes in high-risk women

Gestational diabetes can be prevented by a simple, easily applicable individualized lifestyle intervention in high-risk women, finds a study led by Helsinki University Hospital and South Karelia Central Hospital, Finland. The results of the study are promising, and in line with previous published T2D prevention studies. The findings may have major health consequences for both the mother and the child. [More]

University of Salford’s Midwifery Directorate retains UNICEF Baby Friendly accreditation

The University of Salford’s Midwifery Directorate has retained its UNICEF Baby Friendly accreditation with flying colours after receiving the UK’s highest ever mark. [More]
Female patients with depression have abnormally high expression levels of glutamate receptor genes

Female patients with depression have abnormally high expression levels of glutamate receptor genes

Numerous genes that regulate the activity of a neurotransmitter in the brain have been found to be abundant in brain tissue of depressed females. This could be an underlying cause of the higher incidence of suicide among women, according to research at the University of Illinois at Chicago. [More]
Researchers explore impact of nutrients, probiotics before and during pregnancy on mothers and babies

Researchers explore impact of nutrients, probiotics before and during pregnancy on mothers and babies

Researchers in the United Kingdom (Southampton), Singapore and New Zealand (Auckland) from the EpiGen Global Research Consortium are to trial the use of a combination of nutrients and probiotics before and during pregnancy in a bid to improve the health of mothers and their babies. [More]
New UNSW research shows high-fat maternal diet changes tastebuds of newborn's heart

New UNSW research shows high-fat maternal diet changes tastebuds of newborn's heart

Baby rats whose mothers were fed a high-fat diet had larger than normal hearts with fewer taste receptors for bitter flavours, according to new UNSW research. [More]
Survey finds clear unmet need for comprehensive family planning services at health centers

Survey finds clear unmet need for comprehensive family planning services at health centers

As part of a unique survey of nearly 2,000 women of childbearing age who receive health care at the nation's community health centers, 90 percent reported that they were not actively seeking to become pregnant in the next 12 months. Yet more than 3 out of 10 were not using contraceptives at the time of the survey. [More]
Research brief describes enrollment of first patient with TRK fusion cancer in LOXO-101 Phase 1 trial

Research brief describes enrollment of first patient with TRK fusion cancer in LOXO-101 Phase 1 trial

The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development. [More]
Lidocaine benefits breast cancer survivors who experience pain during intercourse

Lidocaine benefits breast cancer survivors who experience pain during intercourse

Scientists at Oregon Health & Science University report that breast cancer survivors who experience pain during sexual intercourse, a common side effect of breast cancer treatment, may achieve comfort when liquid lidocaine is applied strategically to prevent pain. [More]

CRINONE (progesterone gel) approved in nine new EU countries

Juniper Pharmaceuticals, Inc., a women's health specialty pharmaceutical company, today announced that the regulatory bodies of nine new European Union (EU) countries, including Poland and France, have granted marketing authorization to CRINONE (progesterone gel) under the mutual-recognition procedure (MRP). [More]
RGS2 protein plays significant role in healthy egg-sperm union in mice

RGS2 protein plays significant role in healthy egg-sperm union in mice

Researchers at the National Institutes of Health have discovered a protein that plays a vital role in healthy egg-sperm union in mice. The protein RGS2 can delay an egg's development into an embryo in order to allow time for sperm to arrive and merge with the egg in a healthy fertilization process. The embryo cannot survive without the male chromosomes. [More]
Study shows that home births lead to higher infant mortality among Dutch women living in poorer areas

Study shows that home births lead to higher infant mortality among Dutch women living in poorer areas

Home births lead to higher infant mortality than hospital births, at least for mothers living in poorer areas. This is the conclusion of a new study conducted by N. Meltem Daysal (University of Southern Denmark and IZA), Mircea Trandafir (University of Southern Denmark and IZA) and Reyn van Ewijk (VU University Amsterdam and University of Mainz) that examines 356,412 low-risk Dutch women who delivered between 2000 and 2008 and who were allowed to choose between a home and a hospital birth. [More]
Increased awareness of fertility preservation options needed for young patients with cancer

Increased awareness of fertility preservation options needed for young patients with cancer

A new study points to the need for increased awareness of fertility preservation options for young patients with cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study found that factors such as gender, education, and insurance status may impact whether patients and their physicians have discussions and take actions to preserve fertility during cancer treatment. [More]
Advertisement
Advertisement